Dirk Jacob Ruiter

Dirk Jacob Ruiter's AcademicInfluence.com Rankings

Dirk Jacob Ruiter

Psychology

#3079

World Rank

#3511

Historical Rank

Cognitive Psychology

#347

World Rank

#361

Historical Rank

psychology Degrees

Download Badge

Psychology

Dirk Jacob Ruiter's Degrees

PhD Cognitive Psychology University of California, Berkeley
Masters Cognitive Psychology University of California, Berkeley
Bachelors Psychology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Psychology 2025

Why Is Dirk Jacob Ruiter Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dirk Jacob Ruiter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

How schema and novelty augment memory formation (2012) (620)
Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidney (1986) (378)
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. (2003) (355)
Matrix metalloproteinases in human melanoma. (2000) (343)
Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. (1986) (318)
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial (2005) (291)
Coexpression of intermediate filament polypeptides in human fetal and adult tissues. (1987) (278)
Monoclonal antibody PAL-E specific for endothelium. (1985) (264)
Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. (1989) (250)
Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. (1991) (246)
Differential roles for medial prefrontal and medial temporal cortices in schema-dependent encoding: From congruent to incongruent (2013) (236)
The tumor microenvironment: a critical determinant of neoplastic evolution. (2003) (235)
c‐myc down‐regulates class I HLA expression in human melanomas. (1988) (231)
nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenografts (1995) (227)
Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option (2004) (224)
Melanoma-stroma interactions: structural and functional aspects. (2002) (221)
Angiogenesis in brain tumors; pathobiological and clinical aspects (1997) (219)
Retrieval of Associative Information Congruent with Prior Knowledge Is Related to Increased Medial Prefrontal Activity and Connectivity (2010) (215)
Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. (1990) (209)
Uptake by liver cells of endotoxin following its intravenous injection. (1981) (200)
Molecular genetics and epidemiology of prostate carcinoma. (1999) (195)
Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. (1982) (191)
Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome. (2005) (189)
Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. (1994) (189)
E‐cadherin expression in head and neck squamous‐cell carcinoma is associated with clinical outcome (1993) (182)
Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes (1987) (177)
Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. (1996) (173)
Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. (1984) (167)
Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas (1997) (166)
Demonstration of Intermediate Cells during Human Prostate Epithelial Differentiation In Situ and In Vitro Using Triple-Staining Confocal Scanning Microscopy (2000) (166)
Requirement for the Synergy Site for Cell Adhesion to Fibronectin Depends on the Activation State of Integrin α5β1 (*) (1995) (158)
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression (1999) (157)
Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice (2007) (155)
Aneurysmal bone cysts. A clinicopathological study of 105 cases (1977) (155)
Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. (1988) (154)
Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis. (2002) (153)
Early and Extensive Contribution of Pericytes/Vascular Smooth Muscle Cells to Microvascular Proliferation in Glioblastoma Multiforme: An Immuno‐light and Immuno‐electron Microscopic Study (1995) (149)
Analysis of Mutations in B-RAF, N-RAS, and H-RAS Genes in the Differential Diagnosis of Spitz Nevus and Spitzoid Melanoma (2005) (148)
Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. (1992) (141)
Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. (1990) (138)
Expression of integrin αvβ3 correlates with activation of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) and matrix metalloproteinase‐2 (MMP‐2) in human melanoma cells in vitro and in vivo (2000) (134)
A monoclonal antibody specific for cells of the melanocyte lineage. (1988) (133)
Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis (1997) (132)
Building on Prior Knowledge: Schema-dependent Encoding Processes Relate to Academic Performance (2014) (132)
Expression and activation of matrix metalloproteinase‐2 (MMP‐2) and its co‐localization with membrane‐type 1 matrix metalloproteinase (MT1‐MMP) correlate with melanoma progression (2000) (126)
Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. (1994) (123)
MHC antigens in human melanomas. (1991) (122)
Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. (1993) (118)
Suppression of class I human histocompatibility leukocyte antigen by c- myc is locus specific (1989) (116)
Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy (2001) (116)
T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions. (1995) (113)
Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors. (1984) (112)
Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease. (1994) (112)
Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. (1986) (110)
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. (1994) (105)
Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. (1995) (103)
Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. (1991) (103)
Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. (1998) (102)
Increasing epidermal growth factor receptor expression in human melanocytic tumor progression. (1992) (102)
Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. (2002) (100)
Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. (1993) (99)
Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. (2000) (97)
Coexpression of Integrin αvβ3 and Matrix Metalloproteinase-2 (MMP-2) Coincides with MMP-2 Activation: Correlation with Melanoma Progression (2000) (94)
Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. (1997) (94)
HRAS-mutated Spitz Tumors: A Subtype of Spitz Tumors With Distinct Features (2010) (92)
Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma. (2003) (91)
Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study. (1996) (89)
An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. (1995) (87)
Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. (1993) (85)
Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. (2001) (85)
Cytokeratin and neurofilament in lung carcinomas. (1984) (82)
Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma (1993) (78)
Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. (2002) (78)
Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis. (1998) (78)
Photocarcinogenesis in human adult skin grafts. (2002) (77)
Regulation of integrin‐mediated adhesion to laminin and collagen in human melanocytes and in non‐metastatic and highly metastatic human melanoma cells (1993) (77)
Vascular endothelial growth factor‐A determines detectability of experimental melanoma brain metastasis in GD‐DTPA‐enhanced MRI. (2003) (75)
Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. (1997) (73)
The role of amyloid in the pathogenesis of Alzheimer's disease. (1997) (73)
Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. (1997) (73)
HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas. (1987) (73)
Expression of cd44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential (1995) (72)
Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. (1996) (72)
Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma (1984) (72)
CTp11, a novel member of the family of human cancer/testis antigens. (1999) (71)
Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice (1991) (70)
Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1. (1995) (70)
Multiplex Ligation-Dependent Probe Amplification for the Detection of Chromosomal Gains and Losses in Formalin-Fixed Tissue (2005) (70)
The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. (1995) (68)
Molecular cytogenetics of cutaneous melanocytic lesions – diagnostic, prognostic and therapeutic aspects (2010) (68)
A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics. (1993) (65)
Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi. (1985) (64)
αv‐Integrins in human melanoma: Gain of αvβ3 and loss OF αvβ5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice (1995) (63)
Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization (2003) (61)
Pathologic staging of melanoma. (2002) (61)
Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators (2000) (59)
The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects. (1993) (58)
The Disintegrin Eristostatin Interferes with Integrin α4β1 Function and with Experimental Metastasis of Human Melanoma Cells (1998) (58)
DIAGNOSIS OF RENAL ALLOGRAFT REJECTION BY MACROPHAGE IMMUNOSTAINING WITH A CD14 MONOCLONAL ANTIBODY, WT14 (1989) (57)
Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives. (1988) (57)
Intermediate filaments in Merkel cell tumors. (1985) (56)
Anti‐endothelial cell antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysis (1994) (56)
Angiogenesis in wound healing and tumor metastasis. (1993) (56)
Immunohistochemistry in the evaluation of melanocytic tumors. (1993) (55)
Distribution of major histocompatibility antigens in normal skin (1983) (55)
Expression of calcyclin in human melanocytic lesions. (1993) (55)
The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines. (2003) (55)
The efficacy of histopathological criteria required for diagnosing dysplastic naevi (1988) (54)
Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. (2005) (54)
Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. (2000) (54)
Diffusion tensor characteristics of gyrencephaly using high resolution diffusion MRI in vivo at 7T (2015) (54)
Immunological, cytochemical and ultrastructural studies in lymphomatoid papulosis (1983) (54)
Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer’s disease (1998) (52)
Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage (2006) (52)
Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients (2004) (52)
Phenotype of Normal Cutaneous Microvasculature (1996) (50)
Dendritic reticulum cell sarcoma? Four cases of a lymphoma probably derived from dendritic reticulum cells of the follicular compartment (1982) (50)
Monoclonal antibody-defined human endothelial antigens as vascular markers. (1989) (50)
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases (2003) (49)
Analysis of N-ras mutations in human cutaneous melanoma: tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis. (1995) (49)
Soluble adhesion molecules in human cancers: sources and fates. (2010) (47)
Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the A‚-containing lesions in brains of patients with dementia of the Alzheimer type (1996) (47)
Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma. (1991) (47)
Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. (1994) (47)
Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis (1988) (46)
Thymosin β‐10 expression in melanoma cell lines and melanocytic lesions: A new progression marker for human cutaneous melanoma (1993) (46)
No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited. (1991) (45)
Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo. (2000) (44)
Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis. (1998) (44)
Intermediate cells in normal and malignant prostate epithelium express c‐MET: Implications for prostate cancer invasion (2002) (43)
Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma. (1988) (43)
HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites (1991) (43)
The role of VEGF-C staining in predicting regional metastasis in melanoma (2006) (43)
Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis (2007) (43)
Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms (1993) (43)
Components of the plasminogen activation system in uveal melanoma—a clinico‐pathological study (1995) (43)
Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy. (1990) (42)
Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi. (1985) (42)
Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group. (1998) (42)
Consolidation Differentially Modulates Schema Effects on Memory for Items and Associations (2013) (41)
Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases. (1991) (41)
Tumour metastasis: is tissue an issue? (2001) (41)
Complete response of melanoma-in-transit metastasis after isolated limb perfusion with tumor necrosis factor alpha and melphalan without massive tumor necrosis: a clinical and histopathological study of the delayed-type reaction pattern. (1998) (41)
Heterogeneous expression of melanoma-associated antigens in uveal melanomas. (1987) (40)
The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin αvβ3 expression (2001) (40)
Application of Monoclonal Antibodies in Tumor Pathology (1987) (39)
Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis. (1996) (39)
Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections (1986) (39)
Glycoconjugate profile and cd44 expression in human melanoma cell lines with different metastatic capacity (1995) (38)
Current diagnostic problems in melanoma pathology. (2003) (38)
Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma. (1995) (36)
Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions. (1990) (36)
How to achieve synergy between medical education and cognitive neuroscience? An exercise on prior knowledge in understanding (2010) (36)
DNA in situ hybridization as a diagnostic tool in the discrimination of melanoma and spitz naevus (1994) (35)
Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. (1994) (34)
Improvements and limitations of the subrenal capsule assay for determining tumour sensitivity to cytostatic drugs. (1984) (34)
Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract (2004) (33)
Phenotype of normal cutaneous microvasculature. Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics. (1996) (32)
A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease. (2000) (31)
EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma. (2003) (30)
Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus. (1991) (29)
Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion. (2005) (29)
Molecular markers of melanocytic tumor progression. (1994) (29)
Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx (2005) (28)
Diffuse cutaneous mastocytosis with multiple cutaneous mastocytomas (1980) (28)
Immunohistochemical demonstration of the cytoplasmic copper-associated protein in the liver in primary biliary cirrhosis: its identification as metallothionein. (2008) (28)
Consensus on the management of malignant melanoma of the skin in The Netherlands. Dutch Melanoma Working Party. (1999) (28)
Characteristics and possible function of endoglin, a TGF-beta binding protein. (1993) (27)
Expression of endoglin in psoriatic involved and uninvolved skin. (1995) (27)
Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma. (1994) (27)
A staining procedure for melanin in semithin and ultrathin epoxy section (1983) (26)
Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours (2002) (26)
Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation. (1988) (26)
Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal mntibodies in cryostat sections of biopsies (2004) (25)
Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444 (2000) (24)
Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease. (1999) (24)
P16 and p53 Expression in (Pre)Malignant Epidermal Tumors of Renal Transplant Recipients and Immunocompetent Individuals (2003) (24)
Radiation-induced head and neck tumours: is the skin as sensitive as the thyroid gland? (1983) (24)
Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease. (1998) (23)
Location of HLA-A,B,C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study. (1983) (23)
Anti‐angiogenic treatment of human cancer: Pitfalls and promises (2000) (23)
Integrin expression in uveal melanoma differs from cutaneous melanoma. (1993) (23)
Uncovering students’ misconceptions by assessment of their written questions (2016) (23)
An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1. (1998) (23)
The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression. (2001) (23)
Epitopes of Components of the Plasminogen Activation System are Re-exposed in Formalin-fixed Paraffin Sections by Different Retrieval Techniques (1998) (23)
An altar in honor of the anatomical gift (2010) (22)
The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells. (1998) (22)
Distribution of major histocompatibility antigens in normal skin. (1986) (22)
Immunohistologic evidence for the malignant potential of congenital melanocytic nevi. (1989) (22)
Design of a Variant of Vascular Endothelial Growth Factor-A (VEGF-A) Antagonizing KDR/Flk-1 and Flt-1 (2002) (22)
Stromal responses in human primary melanoma of the skin. (2005) (21)
Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice. (1995) (21)
Report on consensus meeting of the EORTC melanoma group of educational needs for primary and secondary prevention of melanoma in Europe (1991) (21)
Challenging medical students with an interim assessment: a positive effect on formal examination score in a randomized controlled study (2011) (21)
In situ detection of supernumerary aberrations of chromosome-specific repetitive DNA targets in interphase nuclei in human melanoma cell lines and tissue sections. (1992) (21)
Nadroparin-Induced Calcinosis cutis in Renal Transplant Recipients (2001) (21)
Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid (1993) (21)
Melanoma and occupation: results of a case-control study in The Netherlands. (1993) (20)
Differential Expression of Endothelium‐specific Antigen PAL‐E in Vasculature of Brain Tumors and Preexistent Brain Capillaries (1988) (20)
Progression markers in metastasizing human melanoma cells xenografted to nude mice (review). (1989) (19)
Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28 (2002) (19)
Immunology of ocular tumours. (1999) (18)
Loss of adhesion to basement membrane components but not to keratinocytes in proliferating melanocytes. (1996) (18)
Chemodectoma (paraganglioma) of the larynx. (1981) (18)
Transient Induction of E‐Selectin Expression Following TNFα‐Based Isolated Limb Perfusion in Melanoma and Sarcoma Patients Is Not Tumor Specific (1996) (17)
Juxtacortical chondrosarcoma of the mandible: report of a unique case and review of the literature. (2005) (17)
Pathology of malignant melanoma, including new markers and techniques in diagnosis and prognosis. (1996) (17)
Autosomal dominant epidermolysis bullosa dystrophics: are the Cockayne‐ Touraine, the Pasini and the Bart‐types different expressions of the same mutant gene? (1987) (16)
A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques (2004) (16)
Malignant lymphoma of true histiocytic origin: Histiocytic Sarcoma (2004) (16)
Immunodiagnostic and immunotherapeutic applications of anti human melanoma associated antigen monoclonal antibodies. (1989) (16)
Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients. (2002) (15)
Histopathologic findings in explanted heart tissue from patients with end‐stage idiopathic dilated cardiomyopathy (2001) (15)
The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways. (1993) (15)
Endothelial Cells Promote Anti‐CD3‐Induced T‐cell Proliferation via Cell‐Cell Contact Mediated by LFA‐1 and CD2 (1993) (14)
Melanoma progression in a changing environment. (2007) (14)
TCA: a polymorphic genetic marker in leukemias and melanoma cell lines. (1986) (14)
Cytokeratin and vimentin expression in normal epithelium and benign lesions of the vocal cords. (1996) (14)
Functional and morphologic analysis of the fluid-conducting meshwork in xenografted cutaneous and primary uveal melanoma. (2005) (14)
Correlation of scintigraphy with short interval autopsy in malignant focal liver disease. A study of 59 cases (1977) (14)
Accessory Function of Endothelial Cells in Anti‐CD3‐Induced T‐Cell Proliferation: Synergism with Monocytes (1992) (14)
The lysosomal copper concentration in the liver in primary biliary cirrhosis. (2008) (14)
Challenging students to formulate written questions: a randomized controlled trial to assess learning effects (2015) (13)
Clinical and pathologic diagnosis, staging and prognostic factors of melanoma, and management of primary disease (1992) (13)
Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques. (1997) (13)
Metastatic Skin Calcification (1980) (13)
Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy. (1999) (13)
Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results. (1990) (12)
In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities. (2001) (12)
Invasive cutaneous melanoma in The Netherlands, 1989-1990. (1996) (12)
Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapy. (1992) (11)
Aneurysmal bone cyst and telangiectatic osteosarcoma (1977) (11)
On the effect of biochemotherapy in metastatic malignant melanoma: An immunopathological evaluation (2003) (10)
INK4-ARF and p53 Mutations in Metastatic Cutaneous Squamous Cell Carcinoma: Case Report and Archival Study on the Use of Ink4a-ARF and p53 Mutation Analysis in Identification of the Corresponding Primary Tumor (2005) (10)
Cutaneous Melanoma and Precursor Lesions (1984) (10)
Explicit feedback to enhance the effect of an interim assessment: a cross-over study on learning effect and gender difference (2012) (10)
Renal oncocytoma: A report of two cases with immunohistochemical evaluation (1988) (9)
Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study. (2001) (9)
Ichthyosis bullosa of Siemens: Further delineation of the phenotype (2004) (9)
Heparan sulphate epitope–expression is associated with the inflammatory response in metastatic malignant melanoma (2003) (9)
The implications of subjective recognition of malignant cells in aspirations for the grading of prostatic cancer using cell image analysis. (1982) (9)
Radiological imaging of teratological fetuses: what can we learn? (2017) (7)
Protective effect of a brisk tumor infiltrating lymphocyte infiltrate in melanoma: An EORTC melanoma group study (2007) (7)
QUANTITATIVE ANALYSIS OF MICROVASCULAR CHANGES DURING MALIGNANT PROGRESSION IN ASTROCYTIC NEOPLASMS (1996) (7)
Monoclonal antibody MS-44B reacts with human dendritic, glial and endothelial cells: differential expression of MS-44B antigen by epidermal dendritic cells and by MS-1+ splenic sinusoidal endothelial cells. An immunohistological study. (1993) (7)
Integrins and melanoma progression. (1993) (6)
Renal oncocytoma: a report of two cases with immunohistochemical evaluation. (1989) (6)
Induction of a-Smooth Muscle Actin Expression in Cultured Human Brain Pericytes by Transforming Growth Factor-f31 (2007) (6)
[Melanoma-stroma interactions and melanoma progression]. (2003) (5)
The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of Cancer. (2002) (5)
Computer-assisted analysis of the microvasculature in untreated glioblastomas (2005) (5)
Tumor dependent growth kinetics of human tumor xenografts using the subrenal capsule assay. (1985) (5)
Functional and morphological abnormalities of the parathyroid glands as late effects of irradiation for benign diseases. (1985) (5)
Validation of Diffusion Weighted Imaging of cortical anisotropy by means of a histological stain for myelin (2011) (5)
Ultrastructure of normal epithelial cells in Papanicolaou-stained cervical smears. An application of a modified open-face embedding technique for transmission electron microscopy. (1979) (4)
In situ detection of supernumerary aberrations of chromosome-specific repetitive DNA targets in interphase nuclei in human melanoma cell lines and tissue sections (1992) (4)
Immunopathology of Melanoma with Monoclonal Antibodies (1990) (4)
Report on consensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Results of a workshop held under the auspices of the EEC Europe against cancer programme in Innsbruck, April 1991. (1991) (4)
Secreting peritoneal mesothelioma (1981) (4)
Class II HLA Antigens in Benign and Malignant Lesions of Melanocytic Origin (1986) (4)
Expression of HLA antigens in paraffin sections of uveal melanomas (1986) (4)
Involvement of LFA-1/ICAM and CD2/LFA-3 in human endothelial cell accessory function. (1993) (4)
Monoclonal Antibodies Recognizing Melanoma-Associated Antigens. (1987) (4)
A combination of anti-CD 3 and anti-CD 7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease (4)
Differential Diagnosis of Metastatic Lesions in the Lung (1986) (3)
Melanomas and other skin neoplasms. Pathology and case reports. (1990) (3)
Evaluation of consensus development conference on cutaneous melanoma in The Netherlands (1990) (3)
[Evaluation consensus melanoma of the skin based on pathologic-anatomic reports]. (1989) (3)
Immunohistochemistry and special diagnostic techniques (2003) (3)
Macrophages in melanocytic naevi (2004) (3)
Metastatic skin calcification. A rare phenomenon in dialysis patients. (1980) (3)
Monoclonal antibodies in detection of choroidal melanoma (2005) (3)
Integrili p3 cDNA Transfection into a Highly Metastatic av/33-Negative Human Melanoma Cell Line Inhibits Invasion and Experimental Metastasis (2018) (3)
Self-Reflecting Methods of Learning Research (2012) (3)
Cholescintigraphy with99mTc-diethyl-IDA for the detection of rejection of auxiliary liver transplants in pigs (2004) (3)
Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells. (1984) (2)
Immunoelectron microscopy of human melanocytes and other epidermal cells (1984) (2)
HISTOPATHOLOGICAL AsPECTS OF DYSPLASTIC NEVI (1984) (2)
Immunohistopathological Aspects of Cutaneous Melanoma and Precursor Lesions (1984) (2)
[Guideline 'Melanoma' (3rd revision)]. (2005) (2)
[Inflammatory mechanisms in the pathogenesis of Alzheimer's disease]. (1997) (2)
Erratum: Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas. Int. J. Cancer, 71, 320–324 (1997) (1997) (2)
[Thyroid gland carcinoma as a late sequel of irradiation of the neck region]. (1983) (2)
Reactivity of monoclonal antibody NKI/C-3 directed against a melanoma-associated antigen with formalin-fixed paraffin-embedded normal and tumor tissues (1988) (2)
Reproducibility and efficacy of the histopathological criteria used for diagnosing dysplastic naevi: 340 (1993) (2)
Prognostic significance of melanoma-associated antigens in primary and metastatic melanomas (1984) (2)
Mechanisms of melanoma cell adhesion to fibronectin. (1995) (2)
Hypomelanotic macules in tuberous sclerosis (1981) (2)
Primary melanoma in the female distal urethra. (1986) (2)
Advances in Brief Vascular Endothelial Growth Factor-A 165 Induces Progression of Melanoma Brain Metastases without Induction of Sprouting Angiogenesis 1 (2002) (2)
Atypical indifferent (reserve) cells in the cervical epithelium and their exfoliative pattern. (1982) (2)
Epidermal Langerhans cells in erythrokeratodermia variabilis (1982) (2)
Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients. (2003) (2)
Effective d-penicillamine treatment of an early diagnosed patient with Wilson's disease (1984) (1)
Primary “Reticulum Cell Sarcoma” of the Skin:High Frequency of True Histiocytic Lymphoma (Histiocytic Sarcoma) (1982) (1)
Class I and Class II HLA Antigens in Colorectal and Liver Carcinomas (1986) (1)
Suppression of HLA class II expression in human melanoma cells senografted to nude mice (1988) (1)
Pathological Aspects of Colorectal Carcinoma (1980) (1)
Phenotypic heterogeneity of melanoma (1988) (1)
[Revised consensus melanoma of the skin]. (1990) (1)
In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities (2001) (1)
Magnetic resonance imaging in the diagnosis and staging of renal masses: a critical appraisal and comparison with computed tomography (1988) (1)
Antigens CTp11, a Novel Member of the Family of Human Cancer/Testis (1999) (1)
Type I collagen turnover is a critical parameter for melanoma progression (2006) (1)
Immunohistochemical analysis of integrin αvβ3 expression on tumor associated vessels of human carcinomas — Implications for anti-angiogenic treatment approaches (1997) (1)
Cellular and extracellular components of the tumor microvasculature visualized by immuno-histochemistry (1989) (1)
Expression of Calcyclin in Human Melanocytic Lesions1 (2006) (1)
For personal use only. Reproduce with permission from The Lancet Publishing Group. (2001) (1)
Marker in Human Cutaneous Melanoma Expression on Tumor Microvasculature as a New Progression Induction of Vascular Endothelial Growth Factor Receptor-3 Updated (2002) (1)
Accessory molecules utilized by endothelial cells for allogeneic stimulation of T-lymphocytes. (1997) (1)
Sarcoidosis of the liver, complicated by bleeding oesophageal varices. (1982) (1)
115 Plasminogen activation in melanoma: An immuno-histochemical study (1997) (1)
Science of the Internet (2014) (0)
Case 5: Type of Epitheloid and Clear Cell Cancer? (1987) (0)
[Feasibility of a study of the late sequelae of head and neck irradiation]. (1981) (0)
Integrin adhesion profile of human melanoma cells with different metastatic capacities: 249 (1993) (0)
Transmission electron microscopy of uterine cervical papanicolaou-stained smears of normal sexually mature women (1979) (0)
Accessory function of endothelial cells in anti-CD3 induced and allogenic T cell stimulation consists of LFA-1/ICAM and CD2/LFA-3 interactions (1996) (0)
P11 PN-E2, a new monoclonal antibody recognizing activated endothelium in psoriasis (1991) (0)
The role of cytokines in changing pathophysiology of solid tumors that leads to enhanced uptake and efficacy of stealth liposomal doxorubicin or cisplatin (2000) (0)
CORRESPONDENCE (1989) (0)
Clinical pathology of a case of legionnaire's disease (1979) (0)
[Application of monoclonal antibodies in pathologic anatomy studies]. (1985) (0)
Case 3: Type of Sarcoma? (1987) (0)
ICAM expression and microglial activation in Alzheimer senile plaques: Indicators of an inflammatory response (1994) (0)
04 Immunization of melanoma patients with peptide-pulsed dendritic cells (DC) (1999) (0)
Electron microscopy of skin disorders (1979) (0)
[Chronic active hepatitis caused by nitrofurantonin]. (1981) (0)
Editorial Board (2012) (0)
Aneurysmal one syst and teleangiectativ osteosarcoma : a pathological and morphometrical study (1976) (0)
[3 children with a melanoma of the skin]. (1992) (0)
Molecular classification of spitzoid melanocytic lesions: distinct mutations and chromosomal gains and losses (2006) (0)
Histopathological and Cytopathological Aspects of Focal Liver Lesions (1984) (0)
Vascularization of early melanoma in the central nervous system: angiogenesis or cooption? (2001) (0)
FC109 Dysplastic naevi and risk for melanoma: 1997 patient care guidelines in The Netherlands (1997) (0)
Cytokeratin expression patterns in benign lesions of the vocal cords (1996) (0)
A new perspective on the cortical laminar pattern of the primary visual cortex in the occipital lobes (2012) (0)
Dendritic reticulum cell sarcoma: a rare tumor of the follicular compartment. (1982) (0)
Mitogenic activity for endothelial cells in ivtro: a putative novel platelet derived growth factor? (1997) (0)
Late abstracts 186–187 (2005) (0)
The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma. (1990) (0)
[Initial results of preoperative localization of parathyroid adenomas using subtraction scintigraphy with technetium-99m and thallium-201]. (1985) (0)
[Pathogenesis of tumor metastases]. (1995) (0)
Mutation analysis and gene copy number detection as diagnostic aids in the assessment of melanocytic tumors: progress and pitfalls (2008) (0)
MICROVASCULAR CELL-SUBSTRATUM INTEGRINS AND EXTRACELLULAR MATRIX PROTEINS IN HUMAN GLIOBLASTOMA MULTIFORME: 111 (1995) (0)
Activation of ras oncogenes in melanoma, a role for UV? (1993) (0)
4128 Immunoelectron microscopic evaluation of the microvasculature in subretinal neovascular membranes (1995) (0)
withmelanoma-associated monoclonal antibodies inchoroidal melanoma: a comparison oftheclinical andimmunohistochemical results (1990) (0)
NoN-rasmutations inhumanuveal melanoma: Therole ofultraviolet light revisited (1991) (0)
In vitro layer-specific Diffusion Weighted Imaging in human primary visual cortex (2011) (0)
How neuroscience can inform education: A case for prior knowledge effects on memory (2017) (0)
Amiodarone hepatotoxicity. (1986) (0)
cyclin D1 locus amplification and associated increase in cyclin D1 protein expression in the progression of malignant melanoma. ABS-0112 Detection and genomic characterization of occult melanoma cells in sentinel lymph nodes (2006) (0)
Melanocytic tumours in children and adults are genetically different (2007) (0)
Angiogenesis in experimental melanoma metastasis in nude mice (1998) (0)
Epidemiology, Precursors, and Markers of Malignant Melanoma (1988) (0)
The adhesion of T lymphocytes to human endothelial cells and brain pericytes is differentially regulated (1994) (0)
Case 4: Type of Small-Cell Undifferentiated Cancer? (1987) (0)
Laminar characteristics of gyrencephaly using high resolution DTI in vivo at 7 T (2014) (0)
Ultrastructural characterization of 4.4.B positive human cutaneous dendritic cells (1986) (0)
Phenotyping of metastasizing and nonmetastasizing xenografted human melanoma cells (1989) (0)
Conventional light microscopy and electron microscopy on postfixed epoxy resin embedded tissue (1984) (0)